About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
J
Thalassemia Intermedia: Cases and Discussion
By
XV Eurasian Hematology-Oncology Congress - EHOC 2024
FEATURING
Jennifer Abiyounis
By
XV Eurasian Hematology-Oncology Congress - EHOC 2024
FEATURING
Jennifer Abiyounis
2 views
September 16, 2024
0 Comments
Login to view comments.
Click here to Login
Featured Video
12:23
Hematology Content
An ITP Case Study of Treating a Patient Who Was Non-responsive to St…
Feat.
J. Bussel
Featured Video
04:26
Pharmacosmos Hematology
An Introduction to an IV iron replacement therapy
Feat.
H. Bahrain
Related Content
AUTOPLAY
ON
University of Utah Neurology
Postural Tachycardia Syndrome (POTS) & Beyond for Primary Care and S…
Fri, Oct 25, 2024
15:39
Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course
Thalassemias: Overview of Pathophysiology and Treatment
Feat.
K. Fertrin
33:17
Indy Hematology Review
Managing Benign Hematology Disorders
Feat.
C. Kessler
05:59
Stefan Eber
Mitapivat for Thalassemia: Results From the Ph3 ENERGIZE-T Study
42:10
Insights from 2023 ASH Annual Meeting
Highlights in Red Cell and Platelet Disorders From ASH 2023
Feat.
M. Blinder
16:09
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Case-Based Discussion: Managing Non-Transfusion-Dependent Thalassemia
Feat.
A. Taher
33:48
Abdulrahman Nasiri
Beyond Transfusion: Current Treatment Options for Managing Thalassem…
18:15
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient
Updates in Cellular Therapy for Sickle Cell Disease and Beta-Thalass…
Feat.
S. Peslak
13:57
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Pyruvate Kinase Activators - Targeting Red …
Feat.
K. Kuo
08:11
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "A Novel Beta Globin Frameshift Mutation Cau…
Feat.
L. Bilston
10:22
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
State-of-the-Art in Managing Thalassemias
Feat.
M. Cappellini
12:24
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
The Role of Luspatercept in Transfusion-Dependent Patients With Beta…
Feat.
A. Tombak
08:05
Ali Taher
Mitapivat in Adults With Alpha- or Beta-Non-Transfusion-Dependent Th…
08:41
ASH 2022 Conference Coverage
ASH 2022 Long-Term Outcomes of Patients With TDT Followed Up to 8 Ye…
Feat.
M. Walters
19:58
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Luspatercept and Blood Transfusion Management in Beta Thalassemia an…
Feat.
A. Tombak
09:49
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Bu-Cy or Treosulfan-Flu-Thiotepa-Based Myeloablative Conditioning fo…
Feat.
N. Bayram
33:24
Zahra Pakbaz
Current Approach to Sickle Cell Anemia: COVID & SCD, Genotypes, …
31:43
Suhag Parikh
Updates on Curative Therapies for Sickle Cell Disease: Allogeneic HS…
10:26
James Taylor
Forms of SCD: Sickle Cell Anemia, Hb SC Disease, Beta/Alpha-Thalasse…
25:01
Indy Hematology Review
Review of Emerging Therapies and Top Trials in Hematologic Malignanc…
Feat.
R. Birhiray
23:18
XIth Eurasian Hematology-Oncology Congress - EHOC 2020
Curative Options for Hemoglobinopathies: Is MSD the SoC in Thalassem…
Feat.
S. Corbacioglu
